Radesca L, Bowen W D, Di Paolo L, de Costa B R
Laboratory of Medicinal Chemistry, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland 20892.
J Med Chem. 1991 Oct;34(10):3058-65. doi: 10.1021/jm00114a015.
N-Alkyl-substituted derivatives of (+)- and (-)-cis-N-[2-(3,4-dichlorophenyl)ethyl]-2-(1-pyrrolidinyl)cyclohexylamin e have been synthesized in nine steps in a stereospecific manner starting from cyclohexene oxide. The key step in the reaction sequence involved catalytic hydrogenation of oxime 8 in the presence of PtO2 and AcOH to give the cis diamine (+/-)-7. Most of the compounds in this series exhibited very high affinity at sigma receptors when tested against [3H]-(+)-3-PPP, and in general it was observed that the 1R,2S enantiomers bound more potently to sigma receptors than their corresponding 1S,2R enantiomers. The most potent sigma ligand found in this class was the unsubstituted derivative (1R,2S)-(-)-4, which exhibited an affinity constant of 0.49 nM. This compound was also found to be very selective for sigma receptors. It exhibited little or no affinity for kappa opioid, PCP, and dopamine-D2 receptors. It was also demonstrated that the cis configuration as opposed to the trans configuration of (+)- and (-)-5 was necessary for a higher sigma receptor affinity.
以环氧环己烷为起始原料,通过九步立体专一性合成法制备了(+)-和(-)-顺式-N-[2-(3,4-二氯苯基)乙基]-2-(1-吡咯烷基)环己胺的N-烷基取代衍生物。反应序列中的关键步骤是在PtO₂和乙酸存在下,肟8进行催化氢化反应生成顺式二胺(±)-7。当用[³H]-(+)-3-PPP进行测试时,该系列中的大多数化合物对σ受体表现出非常高的亲和力,并且一般观察到1R,2S对映体比其相应的1S,2R对映体与σ受体的结合更有效。该类中发现的最有效的σ配体是未取代的衍生物(1R,2S)-(-)-4,其亲和力常数为0.49 nM。还发现该化合物对σ受体具有高度选择性。它对κ阿片受体、PCP和多巴胺D₂受体几乎没有或没有亲和力。还证明了(+)-和(-)-5的顺式构型与反式构型相比,对于更高的σ受体亲和力是必要的。